Friedemann Kimmich

Switching patients from preserved prostaglandin-analog monotherapy to preservative-free tafluprost

Friedemann Kimmich, Hommer · Clinical ophthalmology · 2011 · 46 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +16

IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucoma

Anton Hommer, Osman Mohammed Ramez, M. Burchert et al. · Current Medical Research and Opinion · 2010 · 42 citations

Medicine, Ophthalmology, Pharmacotherapy +15

Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension

Carl Erb, Ines Lanzl, Seid-Fatima Seidova et al. · Advances in Therapy · 2011 · 33 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +9

Treatment of patients with keratoconjunctivitis sicca with Optive: results of a multicenter, open-label observational study in Germany.

Thomas Kaercher, P. Buchholz, Friedemann Kimmich · PubMed · 2009 · 32 citations

Medicine, Dermatology, Ophthalmology +5

Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study

Lutz E. Pillunat, Carl Erb, Auli Ropo et al. · Clinical ophthalmology · 2017 · 18 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17